← All stocks

Neumora Therapeutics, Inc.

NMRA Net buying

CIK 0001885522 #3643 in the set updated 18 Sep 2026

Bought (12 mo)

$15.00M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.09M

$312.14K on a plan · $701.64K straight out of an exercise

Sold at will

$77.47K

3 of 16 sales

Net

+$13.91M

+$14.92M against sales at will

By person

9 insiders · 19 transactions

16.8×

Paul L. Berns holds 16.8 times base salary in stock. $11.80M of shares against $700.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Paul L. Berns last reported holding, valued at $1.60, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ARCH Venture Partners X, LLC entity

10% owner

$5.00M (1)

—

+$5.00M

6,046,907

3.22%

$9.65M

+46.4%

ARCH Venture Partners XII, LLC entity

10% owner

$5.00M (1)

—

+$5.00M

6,046,907

3.22%

$9.65M

+46.4%

Burow Kristina

Director

$5.00M (1)

—

+$5.00M

6,046,907

3.22%

$9.65M

+46.4%

Aurora Daljit Singh

See Remarks

—

$1.03M (13) scheduled

−$1.03M

48,750

0.0259%

$77.80K

−77.0%

BERNS PAUL L

See Remarks

—

$34.46K (1)

−$34.46K

7,395,185

3.94%

$11.80M

−5.4%

Pinto Joshua

President & CEO

—

$21.09K (1)

−$21.09K

209,950

0.1117%

$335.04K

−6.3%

Milligan Michael Lee

See Remarks

—

$5.12K (1) scheduled

−$5.12K

21,034

0.0112%

$33.57K

−14.0%

Lenz Robert A.

Head of R&D

—

309,092

0.1645%

$493.25K

−8.9%

Fust Matthew K

Director

—

20,100

0.0107%

$32.08K

0.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Aurora Daljit Singh

21 Aug 2026

See Remarks

Sold after exercise indirect

21,055

$1.60

$33.60K

Aurora Daljit Singh

21 Aug 2026

See Remarks

Sold after exercise

20,553

$1.59

$32.78K

Aurora Daljit Singh

20 Aug 2026

See Remarks

Sold after exercise indirect

66,711

$1.51

$101.00K

Aurora Daljit Singh

20 Aug 2026

See Remarks

Sold after exercise

67,741

$1.51

$102.59K

Aurora Daljit Singh

19 Aug 2026

See Remarks

Sold after exercise indirect

30,918

$1.65

$50.89K

Aurora Daljit Singh

19 Aug 2026

See Remarks

Sold after exercise

31,000

$1.65

$51.03K

Aurora Daljit Singh

18 Aug 2026

See Remarks

Sold after exercise indirect

34,987

$1.59

$55.49K

Aurora Daljit Singh

18 Aug 2026

See Remarks

Sold after exercise

34,162

$1.58

$54.14K

Aurora Daljit Singh

17 Aug 2026

See Remarks

Sold after exercise indirect

55,016

$1.50

$82.78K

Aurora Daljit Singh

17 Aug 2026

See Remarks

Sold after exercise

34,020

$1.49

$50.53K

Aurora Daljit Singh

17 Aug 2026

See Remarks

Sold after exercise

57,670

$1.51

$86.82K

Milligan Michael Lee

17 Feb 2026

See Remarks

Sold on a plan

1,436

$3.57

$5.12K

BERNS PAUL L

17 Feb 2026

See Remarks

Sell

9,819

$3.51

$34.46K

Pinto Joshua

17 Feb 2026

President

Sell

5,967

$3.54

$21.09K

Aurora Daljit Singh

17 Feb 2026

See Remarks

Sell

6,165

$3.56

$21.92K

Aurora Daljit Singh

11 Nov 2025

See Remarks

Sold on a plan indirect

114,703

$2.68

$307.03K

ARCH Venture Partners X, LLC

27 Oct 2025

10% owner

Buy indirect

1,915,700

$2.61

$5.00M

ARCH Venture Partners XII, LLC

27 Oct 2025

10% owner

Buy indirect

1,915,700

$2.61

$5.00M

Burow Kristina

27 Oct 2025

Director

Buy indirect

1,915,700

$2.61

$5.00M

Neumora Therapeutics, Inc.

By person

Individual transactions

What was left out